BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33007114)

  • 1. Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.
    Bergerot CD; Philip EJ; Bergerot PG; Hsu J; Dizman N; Salgia M; Salgia N; Vaishampayan U; Battle D; Loscalzo M; Dale W; Pal SK
    Cancer; 2021 Feb; 127(3):354-358. PubMed ID: 33007114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
    Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
    Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
    Steffen McLouth LE; Lycan TW; Levine BJ; Gabbard J; Ruiz J; Farris M; Grant SC; Pajewski NM; Weaver KE; Petty WJ
    Clin Lung Cancer; 2020 May; 21(3):255-263.e4. PubMed ID: 31917067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distress and Quality of Life Among Patients with Advanced Genitourinary Cancers.
    Bergerot CD; Philip EJ; Bergerot PG; Pal SK
    Eur Urol Focus; 2020 Nov; 6(6):1150-1154. PubMed ID: 31711933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy.
    Bergerot CD; Bergerot PG; Philip EJ; Hsu JA; Dizman N; Vaishampayan U; Dorff T; Pal SK
    J Immunother Cancer; 2019 Mar; 7(1):71. PubMed ID: 30867071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
    Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
    Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
    Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
    Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
    Yang F; Markovic SN; Molina JR; Halfdanarson TR; Pagliaro LC; Chintakuntlawar AV; Li R; Wei J; Wang L; Liu B; Nowakowski GS; Wang ML; Wang Y
    JAMA Netw Open; 2020 Aug; 3(8):e2012534. PubMed ID: 32766800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.
    Murakawa Y; Sakayori M; Otsuka K
    BMC Palliat Care; 2019 Jun; 18(1):45. PubMed ID: 31159782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Reported Functional Status in Outpatients With Advanced Cancer: Correlation With Physician-Reported Scores and Survival.
    Popovic G; Harhara T; Pope A; Al-Awamer A; Banerjee S; Bryson J; Mak E; Lau J; Hannon B; Swami N; Le LW; Zimmermann C
    J Pain Symptom Manage; 2018 Jun; 55(6):1500-1508. PubMed ID: 29496534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.
    Brown PD; Ballman KV; Rummans TA; Maurer MJ; Sloan JA; Boeve BF; Gupta L; Tang-Wai DF; Arusell RM; Clark MM; Buckner JC
    J Neurooncol; 2006 Feb; 76(3):283-91. PubMed ID: 16163448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patient-rated performance status affect treatment decisions in advanced lung cancer?
    Dajczman E; Kasymjanova G; Kreisman H; Swinton N; Pepe C; Small D
    J Thorac Oncol; 2008 Oct; 3(10):1133-6. PubMed ID: 18827609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy in patient-rated and oncologist-rated performance status on depression and anxiety in cancer: a prospective study protocol.
    Mei Hsien CC; Wan Azman WA; Md Yusof M; Ho GF; Krupat E
    BMJ Open; 2012; 2(5):. PubMed ID: 23035016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status.
    Gmür A; Kolly P; Knöpfli M; Dufour JF
    Liver Int; 2018 Aug; 38(8):1468-1474. PubMed ID: 29389088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Radiation Therapy on Aggressive Care and Quality of Life Near Death.
    Li D; Prigerson HG; Kang J; Maciejewski PK
    J Pain Symptom Manage; 2017 Jan; 53(1):25-32. PubMed ID: 27720786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists.
    Kim YJ; Hui D; Zhang Y; Park JC; Chisholm G; Williams J; Bruera E
    J Pain Symptom Manage; 2015 Jun; 49(6):1050-1058.e2. PubMed ID: 25542550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.